Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment-Reference-Cited by-同舟云学术

Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment

Published:2022-08 Issue: Volume:187 Page:114357
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Tarannum Mubin,Vivero-Escoto Juan L.^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference164 articles.

1. Cancer Statistics, 2021, CA;Siegel;Cancer J. Clin.,2021

2. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors., World;Rawla;J Oncol.,2019

3. Refined TNM-staging for pancreatic adenocarcinoma – Real progress or much ado about nothing?;Roalsø;Eur. J. Surg. Oncol.,2020

4. P. Nelly Adel BCOP, BCPS, Current Treatment Landscape and Emerging Therapies for Pancreatic Cancer, Suppl. Featur. Publ. 25 (2019). https://www.ajmc.com/view/current-treatment-landscape--and-emerging-therapies-for-pancreatic-cancer.

5. KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer;Cicenas;Cancers (Basel).,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in Irinotecan-loaded nanomaterials as a smart drug delivery system for cancer therapy: A state-of-art-review;Inorganic Chemistry Communications;2024-03

2. CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy;Cancer Letters;2024-03

3. Metallic nanoparticles-based drug delivery for pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

4. Pancreatic Cancer: Updates in Pathogenesis and Therapies;Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies;2023-11-02

5. Modular Fabrication of Bioorthogonal Nanozymes for Biomedical Applications;Advanced Materials;2023-10-18